
|Articles|May 1, 2003
Consider efficacy, effectiveness, safety to prove all-around value of a drug
Author(s)Mari Edlin
FMCP model urges plans to think outside the cost silo when making formulary decisions
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
COVID-19 vaccines could help tumors respond better to immune checkpoint inhibitors
2
Researchers highlight DR-70 as a possible biomarker for early bladder cancer detection
3
Gilead’s Single-Tablet HIV Regimen Meets Primary Endpoints
4
FDA approves Poherdy, first biosimilar of Perjeta, to treat HER-positive breast cancer
5


















































